Rushab R Choksi
Overview
Explore the profile of Rushab R Choksi including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
4
Citations
13
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Penn M, MacRae C, Goldfaden R, Choksi R, Smith S, Wrenn D, et al.
PLoS One
. 2023 Jul;
18(7):e0288712.
PMID: 37471318
Background: Levels of free myeloperoxidase (MPO), a cardiovascular risk marker, have been reported to decline with standard care. Whether such declines signify decreased risk of mortality remains unknown. Design: Cox...
2.
A Review of the Efficacy and Tolerability of Bempedoic Acid in the Treatment of Hypercholesterolemia
Niman S, Rana K, Reid J, Sheikh-Ali M, Lewis T, Choksi R, et al.
Am J Cardiovasc Drugs
. 2020 Mar;
20(6):535-548.
PMID: 32166726
Despite the widespread use of statins and ezetimibe to decrease low-density lipoprotein cholesterol (LDL-C) levels and associated atherosclerotic cardiovascular disease (ASCVD), many patients do not achieve adequate LDL-C lowering as...
3.
Reid J, Rana K, Niman S, Sheikh-Ali M, Lewis T, Choksi R, et al.
Am J Cardiovasc Drugs
. 2020 Feb;
20(5):419-429.
PMID: 32043244
Cardiovascular disease (CVD) is the leading cause of morbidity and mortality in patients with type 2 diabetes mellitus (T2DM). Because of these associated risks, managing diabetes and CVD, including heart...
4.
Rana K, Reid J, Rosenwasser J, Lewis T, Sheikh-Ali M, Choksi R, et al.
Diabetes Metab Syndr Obes
. 2019 Oct;
12:1897-1911.
PMID: 31571964
Diabetes is a significant and independent risk factor for atherosclerotic cardiovascular disease (ASCVD), leading to morbidity and mortality among this population. The prevention of macrovascular complications, such as CVD, peripheral...